Literature DB >> 30166759

Rheumatic heart disease in North Darfur: an alarmingly high burden and control initiative.

Nagwa Salih1, Ishaag Eisa1, Daresalam Ishag1, Intisar Ibrahim2, Sulafa Ali3,4.   

Abstract

Rheumatic heart disease (RHD) is the most common cause of cardiac morbidity in Sudanese young people and it is particularly prevalent in Darfur area. A retrospective review of clinical and echocardiography (echo) data for children with RHD seen in Al Fashir Hospital from 2010 to 2016 was conducted. Data from the hospital statistics, outpatient and echo clinic records were collected and analysed. A control program was started based on training modules and public awareness material. In the study period, 324 patients were admitted and 3,777 patients with RHD were seen in outpatient clinics. Complications occurred in 33% of inpatients with a case fatality of 12%. Echo revealed that 83% of patients have severe disease and 50% have a combination of more than two valves affected. Training of 50 medical assistants, 30 physicians and 10 health promoters was achieved. Public awareness programs were conducted. We found a significant burden of RHD in Al Fashir Hospital. A control program was initiated that needs substantial support from governmental and nongovernmental organizations.

Entities:  

Keywords:  Darfur; Rheumatic heart disease; Sudan

Year:  2018        PMID: 30166759      PMCID: PMC6113776          DOI: 10.24911/SJP.2018.1.4

Source DB:  PubMed          Journal:  Sudan J Paediatr        ISSN: 0256-4408


  6 in total

1.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography.

Authors:  William A Zoghbi; Maurice Enriquez-Sarano; Elyse Foster; Paul A Grayburn; Carol D Kraft; Robert A Levine; Petros Nihoyannopoulos; Catherine M Otto; Miguel A Quinones; Harry Rakowski; William J Stewart; Alan Waggoner; Neil J Weissman
Journal:  J Am Soc Echocardiogr       Date:  2003-07       Impact factor: 5.251

2.  Clinical outcomes in 1731 patients undergoing mitral valve surgery for rheumatic valve disease.

Authors:  Wan Kee Kim; Ho Jin Kim; Joon Bum Kim; Sung-Ho Jung; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee
Journal:  Heart       Date:  2017-11-16       Impact factor: 5.994

3.  Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study).

Authors:  Liesl Zühlke; Mark E Engel; Ganesan Karthikeyan; Sumathy Rangarajan; Pam Mackie; Blanche Cupido; Katya Mauff; Shofiqul Islam; Alexia Joachim; Rezeen Daniels; Veronica Francis; Stephen Ogendo; Bernard Gitura; Charles Mondo; Emmy Okello; Peter Lwabi; Mohammed M Al-Kebsi; Christopher Hugo-Hamman; Sahar S Sheta; Abraham Haileamlak; Wandimu Daniel; Dejuma Y Goshu; Senbeta G Abdissa; Araya G Desta; Bekele A Shasho; Dufera M Begna; Ahmed ElSayed; Ahmed S Ibrahim; John Musuku; Fidelia Bode-Thomas; Basil N Okeahialam; Olukemi Ige; Christopher Sutton; Rajeev Misra; Azza Abul Fadl; Neil Kennedy; Albertino Damasceno; Mahmoud Sani; Okechukwu S Ogah; Taiwo Olunuga; Huda H M Elhassan; Ana Olga Mocumbi; Abiodun M Adeoye; Phindile Mntla; Dike Ojji; Joseph Mucumbitsi; Koon Teo; Salim Yusuf; Bongani M Mayosi
Journal:  Eur Heart J       Date:  2014-11-25       Impact factor: 29.983

4.  Genes, autoimmunity and pathogenesis of rheumatic heart disease.

Authors:  L Guilherme; K F Köhler; E Postol; J Kalil
Journal:  Ann Pediatr Cardiol       Date:  2011-01

Review 5.  The state of heart disease in Sudan.

Authors:  A Suliman
Journal:  Cardiovasc J Afr       Date:  2011 Jul-Aug       Impact factor: 1.167

6.  Rheumatic Heart Disease Severity, Progression and Outcomes: A Multi-State Model.

Authors:  Jeffrey Cannon; Kathryn Roberts; Catherine Milne; Jonathan R Carapetis
Journal:  J Am Heart Assoc       Date:  2017-03-02       Impact factor: 5.501

  6 in total
  1 in total

1.  Moving forwards amidst the griefs.

Authors:  Mustafa Abdalla M Salih; Mohammed Osman Swar
Journal:  Sudan J Paediatr       Date:  2022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.